Condition: Embolism and Thrombosis · Cardiovascular · Renal · Sponsor: LumiraDx UK Limited
To research and develop new state of the art diagnostic biomarkers on the LumiraDx Platform that are comparable to the approved gold standard reference methods and will radically enhance clinicians and patients ability to monitor health conditions and improve outcomes by delivering the results near patient at the point of care.
This description comes directly from the study's public registry record.
David Craig · 0044 1786 533232 · novel-2@lumiradx.com
Always discuss trial participation with your own doctor first.
| University Hospital Monklands | Airdrie, Scotland, United Kingdom | Recruiting |
| Royal Infirmary of Edinburgh | Edinburgh, Scotland, United Kingdom | Recruiting |
| St John's Hospital | Edinburgh, Scotland, United Kingdom | Recruiting |
| Glasgow Royal Infirmary | Glasgow, Scotland, United Kingdom | Recruiting |
| Queen Elizabeth University Hospital | Glasgow, Scotland, United Kingdom | Recruiting |
| Golden Jubilee National Hospital | Glasgow, Scotland, United Kingdom | Recruiting |
| Royal Alexandra Hospital | Paisley, Scotland, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05568966